ResearcherFudan UniversityNo recent work listed

Xiu-Yun Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6045-8027; OpenAlex author ID A5090922199. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper

Papers 1

Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound. Co-author DOI 10.3390/diagnostics12112662 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dan Zuo · 1 shared paper, 2022 · strength 0.15
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662 ↗
Qi Zhang · 1 shared paper, 2022 · strength 0.15
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662 ↗
Xi Guo · 1 shared paper, 2022 · strength 0.15
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662 ↗
Wen‐Ping Wang · 1 shared paper, 2022 · strength 0.15
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662 ↗
Yijie Qiu · 1 shared paper, 2022 · strength 0.15
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662 ↗
Yuhong Zhou · 1 shared paper, 2022 · strength 0.15
- Paper Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contras… DOI 10.3390/diagnostics12112662 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.